Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

11 Apr 2017

Abstract excerpt

Abstract Purpose: Hypoxia modification improves overall survival in muscle-invasive bladder cancer patients who undergo radiotherapy. There is evidence that hypoxic tumors benefit most from hypoxia modification. The study aimed to identify or derive a hypoxia gene signature that predicts benefit from hypoxia-modifying treatment in bladder cancer. Experimental Design: Published hypoxia signatures were tested and a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Epigenetics and DNA Methylation
Share to Radiation Therapy and Dosimetry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28400426
DOI: 10.1158/1078-0432.ccr-17-0038

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer PatientsPMID 28400426Read ↗

Gene Expression in Muscle-Invasive and Non-Muscle-Invasive Bladder Cancer Cells Exposed to HypoxiaSemantic proximity Read ↗

Hypoxia score for predicting prognosis and tumor response to immunotherapy in bladder urothelial carcinomaSemantic proximity Read ↗

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancerSemantic proximity Read ↗

Identification and Validation of A Hypoxia-Related Prognostic and Immune Microenvironment Signature in Bladder CancerSemantic proximity Read ↗

A Novel Hypoxia-Related Signature for Predicting Prognosis, Immune Characteristics, and Therapeutic Response in Hepatocellular CarcinomaSemantic proximity Read ↗

Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxiaSemantic proximity Read ↗

Transcriptomics-Driven Machine Learning Models Accurately Predict Chemotherapy Response in Muscle-invasive Bladder CancerSemantic proximity Read ↗

Genomic Machine Learning Model Predicts Radiation Therapy Benefit in Early-Stage Breast Cancer Patients with High AccuracySemantic proximity Read ↗

Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancerSemantic proximity Read ↗

Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast CancerSemantic proximity Read ↗

Construction and validation of a hypoxia-related gene signature to predict the prognosis of invasive ductal breast carcinomaSemantic proximity Read ↗

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.